VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
0.7702
-0.0748 (-8.85%)
At close: Aug 28, 2025, 4:00 PM
0.7653
-0.0049 (-0.64%)
After-hours: Aug 28, 2025, 7:58 PM EDT
VSee Health Stock Forecast
VSEE's stock price has decreased by -53.88% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for VSee Health stock has a target of 5.00, which predicts a 549.18% increase from the current stock price of 0.77.
Price Target: $5.00 (+549.18%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 24, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for VSee Health is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +549.18% | Feb 24, 2025 |
Financial Forecast
Revenue This Year
10.29M
from 5.84M
Increased by 76.10%
Revenue Next Year
16.95M
from 10.29M
Increased by 64.83%
EPS This Year
-0.03
from -0.34
EPS Next Year
-0.37
from -0.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.6M | 17.5M | |
| Avg | 10.3M | 17.0M | |
| Low | 9.9M | 16.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 81.3% | 69.7% | |
| Avg | 76.1% | 64.8% | |
| Low | 69.2% | 58.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.03 | -0.38 | |
| Avg | -0.03 | -0.37 | |
| Low | -0.03 | -0.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.